EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The MYCN 5′ UTR as a therapeutic target in neuroblastoma

Marina P Volegova, Lauren E Brown, Ushashi Banerjee, Ruben Dries, Bandana Sharma, Alyssa Kennedy, John A Porco, Rani E George

Cell Reports · 2024-05 · 43 (5) · 114134

DOI: 10.1016/j.celrep.2024.114134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-05. Verfasst von Marina P Volegova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, …. Hauptthemen laut MEDLINE: 5' Untranslated Regions, Eukaryotic Initiation Factor-4A, N-Myc Proto-Oncogene Protein, Neuroblastoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5' Untranslated RegionsEukaryotic Initiation Factor-4AN-Myc Proto-Oncogene ProteinNeuroblastomaAnimalsHumansMiceCell Line, TumorCell ProliferationRNA, MessengerFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

CP: CancerCP: Molecular biologyMYCNMYCN amplificationPAR-CLIPamidino-rocaglateeIF4A1neuroblastomaribosome profilingrocaglatetranslationtranslation regulation

Substanzen

5' Untranslated RegionsEukaryotic Initiation Factor-4AMYCN protein, humanN-Myc Proto-Oncogene ProteinRNA, MessengerEIF4A1 protein, human

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Boston University, Center for Molecular Discovery (BU-CMD), Boston, MA, USA; Boston University, Department of Chemistry, Boston, MA, USA.
  • Boston University School of Medicine, Computational Biomedicine, Boston, MA, USA.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Boston Children's Cancer and Blood Disorders Center, Pediatric Hematology/Oncology, Boston, MA, USA.
  • Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA. Electronic address: rani_george@dfci.harvard.edu.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • Alex's Lemonade Stand Foundation for Childhood Cancer

Zitieren

APA

Volegova, M. P., Brown, L. E., Banerjee, U., Dries, R., Sharma, B., Kennedy, A., Porco, J. A., & George, R. E. (2024). The MYCN 5′ UTR as a therapeutic target in neuroblastoma. Cell Reports, 43(5), 114134. https://doi.org/10.1016/j.celrep.2024.114134

Vancouver

Volegova MP, Brown LE, Banerjee U, Dries R, Sharma B, Kennedy A, et al. The MYCN 5′ UTR as a therapeutic target in neuroblastoma. Cell Reports. 2024;43(5):114134. doi:10.1016/j.celrep.2024.114134

BibTeX
@article{Volegova2024,
  author = {Volegova, Marina P and Brown, Lauren E and Banerjee, Ushashi and Dries, Ruben and Sharma, Bandana and Kennedy, Alyssa and Porco, John A and George, Rani E},
  title = {The MYCN 5′ UTR as a therapeutic target in neuroblastoma},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {5},
  pages = {114134},
  doi = {10.1016/j.celrep.2024.114134}
}
Kostenlos starten →